On May 2nd, 2024, Rensource Energy, Africa’s fastest growing solar power provider for the Commercial and Industrial Sector (C&I) made public its installation of a 300kWp carport solar energy for Institute of Human Virology Nigeria (“IHVN”). The aim of the installation is to reduce their dependency on the grid and diesel while providing a clean, affordable, and reliable source of power.
The solar energy installation would generate 436MWh annually and offset 4,293 metric tonnes of CO2 over the project’s lifetime. This installation also contributes to the advancement of the net zero target by 2050.
“Having reviewed some of the projects Rensource did in the past, we found out that their credibility is high. This propelled us to work with the organization and they did not disappoint us. They deployed a unique technology into our facility, the finish was excellent in terms of the quality of product used and the actual installation. We are glad to have installed this solar energy solution as it was very timely” stated Dr. Charles Olalekan Mensah, Chief Operating Officer and Managing Director of Institute of Human Virology, Nigeria.
“We are thrilled to have installed this cutting-edge carport solar solution for Institute of Human Virology, Nigeria (IHVN) with the sole purpose of bridging their energy gap. We look forward to seeing the project’s impact on IHVN’s overall business operations and advancing the SDG Goal 7 (Affordable and Clean Energy), SDG Goal 11 (Sustainable Cities and Communities), and SDG Goal 13 (Climate Action)” commented Prince Ojeabulu, the CEO of Rensource Energy
About Rensource Energy
Rensource Energy is a leading C&I solar power provider in Africa. Rensource currently designs, funds, and delivers solar solutions to diverse C&I clients across Africa. The company’s solutions offer affordable and reliable clean energy to clients, making it a superior choice for SMEs and Industrial Clients looking to reduce their cost of electricity.
Rensource is backed by leading investors, among which are Persistent Energy and EDP Holding
About IHVN
The Institute of Human Virology, Nigeria (“IHVN”) is a non-governmental organization established in 2004 to address the HIV/AIDS crisis in Nigeria by developing infrastructure for treatment, care, prevention, and support for people living with and those affected with HIV/AIDS. IHVN has expanded its services to other infectious diseases like tuberculosis, malaria and non-infectious diseases, including cancers.
As a local organization, the Institute is structured to develop and maintain collaborative linkages within and outside the country in support of the Government of Nigeria’s health sector strategic plans. IHVN’s key technical and funding partners include the Centers for Disease Control and Prevention (CDC), the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the United States Agency for International Development (USAID).
